1416165-11-1

Basic information

• Product Name: (2S,3S,4R,5S,6S)-2-(4-chloro-3-(4-(trifluoromethylsulfonyloxy)benzyl)phenyl)-6-methoxytetrahydro-2H-pyran-3,4,5-triyl triacetate
• Synonyms: (2S,3S,4R,5S,6S)-2-(4-chloro-3-(4-(trifluoromethylsulfonyloxy)benzyl)phenyl)-6-methoxytetrahydro-2H-pyran-3,4,5-triyl triacetate
• CAS NO: 1416165-11-1
• Molecular Weight: 639
• Mol File: 1416165-11-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (2S,3S,4R,5S,6S)-2-(4-chloro-3-(4-(trifluoromethylsulfonyloxy)benzyl)phenyl)-6-methoxytetrahydro-2H-pyran-3,4,5-triyl triacetate(CAS DataBase Reference)
• NIST Chemistry Reference: (2S,3S,4R,5S,6S)-2-(4-chloro-3-(4-(trifluoromethylsulfonyloxy)benzyl)phenyl)-6-methoxytetrahydro-2H-pyran-3,4,5-triyl triacetate(1416165-11-1)
• EPA Substance Registry System: (2S,3S,4R,5S,6S)-2-(4-chloro-3-(4-(trifluoromethylsulfonyloxy)benzyl)phenyl)-6-methoxytetrahydro-2H-pyran-3,4,5-triyl triacetate(1416165-11-1)

Safety Data

• Hazardous Substances Data: 1416165-11-1(Hazardous Substances Data)

Upstream product

• 1416165-10-0 (3S,4R,5S,6S)-2-bromo-6-(4-chloro-3-(4-hydroxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate 
• 1309963-55-0 (3S,4R,5S,6S)-6-(3-(4-acetoxybenzyl)-4-chlorophenyl)tetrahydro-2H-pyran-2,3,4,5-tetrayl tetraacetate 
• 1018898-77-5 (3aS,5R,6R,6aS)-6-(tert-butyl-dimethyl-silanyloxy)-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxole-5-carbaldehyde 
• 864070-19-9 [4-(5-bromo-2-chloro-benzyl)-phenoxy]-tert-butyl-dimethyl-silane 
• 358-23-6 trifluoromethylsulfonic anhydride 
• 1309963-57-2 (2S,3S,4R,5S,6S)-2-(4-chloro-3-(4-hydroxybenzyl)phenyl)-6-methoxytetrahydro-2H-pyran-3,4,5-triyl triacetate 

Downstream Products

• 1416165-12-2 (2S,3S,4R,5S,6S)-2-(4-chloro-3-(4-cyanobenzyl)phenyl)-6-methoxytetrahydro-2H-pyran-3,4,5-triyl triacetate 
• 1416165-32-6 (2S,3S,4R,5S,6S)-2-(4-chloro-3-(4-((trimethylsilyl)ethynyl)benzyl)phenyl)-6-methoxytetrahydro-2H-pyran-3,4,5-triyl triacetate 
• 1416165-33-7 (2S,3S,4R,5S,6S)-2-(3-(4-acetylbenzyl)-4-chlorophenyl)-6-methoxytetrahydro-2H-pyran-3,4,5-triyl triacetate 
• 1416164-49-2 1-(4-(2-chloro-5-((2S,3R,4R,5S,6S)-3,4,5-trihydroxy-6-methoxytetrahydro-2H-pyran-2-yl)benzyl)phenyl)ethanone O-ethyl oxime 
• 1416165-13-3 4-(2-chloro-5-((2S,3R,4R,5S,6S)-3,4,5-trihydroxy-6-methoxytetrahydro-2H-pyran-2-yl)benzyl)benzonitrile 
• 1416165-14-4 1-(4-(2-chloro-5-((2S,3R,4R,5S,6S)-3,4,5-trihydroxy-6-methoxytetrahydro-2H-pyran-2-yl)benzyl)phenyl)ethanone 
• 1416164-41-4 1-(4-(2-chloro-5-((2S,3R,4R,5S,6S)-3,4,5-trihydroxy-6-methoxytetrahydro-2H-pyran-2-yl)benzyl)phenyl)ethanone O-methyl oxime 

Relevant articles and documents

NOVEL SGLT INHIBITORS

The present invention relates to novel compounds of Formula (I), their pharmaceutically acceptable derivatives, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of Formula (I), their pharmaceutically acceptable derivatives, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising novel compounds of Formula (I) and methods of treating or preventing one or more conditions or diseases that may be regulated or normalized via inhibition of Sodium Glucose Cotransporter-2 (SGLT-2).